AQR Capital Management Portfolio holdings
AUM $121B
1-Year Return
23.38%
This Quarter Return
+11.79%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$121B
AUM Growth
+$23.8B
(+25%)
Cap. Flow
+$14.7B
Cap. Flow
% of AUM
12.13%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
3,434
New
284
Increased
1,844
Reduced
1,127
Closed
142
Top Buys
| 1 |
PNC Financial Services
PNC
|
+$357M |
| 2 |
Monster Beverage
MNST
|
+$348M |
| 3 |
Veeva Systems
VEEV
|
+$278M |
| 4 |
Expedia Group
EXPE
|
+$249M |
| 5 |
Manhattan Associates
MANH
|
+$246M |
Top Sells
| 1 |
ConocoPhillips
COP
|
+$299M |
| 2 |
Comcast
CMCSA
|
+$261M |
| 3 |
Airbnb
ABNB
|
+$210M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$208M |
| 5 |
Meta Platforms (Facebook)
META
|
+$182M |
Sector Composition
| 1 | Technology | 25.04% |
| 2 | Financials | 15.03% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Healthcare | 12.06% |
| 5 | Industrials | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
UnitedHealth
UNH
$309B
| $313M | 0.26% |
1,017,650
+232,961
| +30% | +$71.6M |
|
77
Tapestry
TPR
$22.9B
| $311M | 0.26% |
3,546,969
+939,227
| +36% | +$82.5M |
|
78
DraftKings
DKNG
$21.2B
| $307M | 0.25% |
7,147,665
+2,451,421
| +52% | +$105M |
|
79
BioMarin Pharmaceuticals
BMRN
$10.4B
| $306M | 0.25% |
5,580,573
+2,654,768
| +91% | +$146M |
|
80
Amphenol
APH
$145B
| $302M | 0.25% |
3,093,952
-181,879
| -6% | -$17.8M |
|
81
CarMax
KMX
$8.87B
| $298M | 0.25% |
4,457,340
+2,947,996
| +195% | +$197M |
|
82
Toll Brothers
TOL
$13.5B
| $298M | 0.25% |
2,607,993
+1,183,304
| +83% | +$135M |
|
83
Autodesk
ADSK
$68B
| $297M | 0.25% |
967,469
+394,768
| +69% | +$121M |
|
84
Delta Air Lines
DAL
$38.4B
| $296M | 0.24% |
6,012,856
+48,974
| +0.8% | +$2.41M |
|
85
Northrop Grumman
NOC
$82.6B
| $296M | 0.24% |
598,474
-300,640
| -33% | -$149M |
|
86
Arrow Electronics
ARW
$6.13B
| $295M | 0.24% |
2,313,997
+1,311,972
| +131% | +$167M |
|
87
Johnson Controls International
JCI
$70.3B
| $295M | 0.24% |
2,806,827
+772,767
| +38% | +$81.1M |
|
88
Natera
NTRA
$24.1B
| $292M | 0.24% |
1,726,750
+532,769
| +45% | +$90M |
|
89
Hilton Worldwide
HLT
$62.7B
| $287M | 0.24% |
1,081,602
+268,987
| +33% | +$71.4M |
|
90
Synchrony
SYF
$27.8B
| $285M | 0.24% |
4,266,366
+245,527
| +6% | +$16.4M |
|
91
Bank of New York Mellon
BK
$75.5B
| $284M | 0.24% |
3,117,445
-126,759
| -4% | -$11.5M |
|
92
Bristol-Myers Squibb
BMY
$93.9B
| $281M | 0.23% |
6,067,940
+98,910
| +2% | +$4.58M |
|
93
IBM
IBM
$241B
| $278M | 0.23% |
948,589
+120,074
| +14% | +$35.1M |
|
94
Tyson Foods
TSN
$19.3B
| $277M | 0.23% |
5,006,787
+2,164,160
| +76% | +$120M |
|
95
Molina Healthcare
MOH
$9.56B
| $273M | 0.23% |
925,672
+40,714
| +5% | +$12M |
|
96
Gilead Sciences
GILD
$139B
| $272M | 0.23% |
2,470,838
+606,168
| +33% | +$66.8M |
|
97
Citizens Financial Group
CFG
$22.5B
| $272M | 0.23% |
6,079,239
-1,287,515
| -17% | -$57.6M |
|
98
Altria Group
MO
$110B
| $271M | 0.22% |
4,643,814
-886,363
| -16% | -$51.8M |
|
99
3M
MMM
$82.6B
| $271M | 0.22% |
1,781,080
-652,069
| -27% | -$99.2M |
|
100
Eli Lilly
LLY
$681B
| $270M | 0.22% |
346,975
-220,528
| -39% | -$171M |
|